Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)
CUSIP: 03237H101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,540,561
- Total 13F shares
- 43,632,024
- Share change
- -5,832,242
- Total reported value
- $82,904,189
- Put/Call ratio
- 413%
- Price per share
- $1.90
- Number of holders
- 115
- Value change
- -$16,885,307
- Number of buys
- 60
- Number of sells
- 94
Quarterly Holders Quick Answers
What is CUSIP 03237H101?
CUSIP 03237H101 identifies AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03237H101:
Top shareholders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ALS Invest 1 B.V. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,895,280
|
$96,258,721 | — | 06 Jul 2022 | |
| Morningside Venture Investments Ltd |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,997,302
|
$81,596,447 | — | 15 Aug 2023 | |
| DRAGSA 96 LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,300,000
|
$37,554,630 | — | 11 Jan 2022 | |
| VIKING GLOBAL INVESTORS LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,850,940
|
$30,222,333 | — | 08 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.9%
|
5,348,139
|
$15,188,715 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.1%
|
4,474,722
|
$12,708,211 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.7%
|
2,943,186
|
$8,358,649 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.3%
|
2,471,455
|
$7,018,932 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
2,070,653
|
$5,880,656 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
2,060,042
|
$5,850,519 | — | 31 Mar 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.7%
|
1,855,886
|
$5,270,716 | — | 31 Mar 2024 | |
| Margaret Olinger |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
320,685
mixed-class rows
|
$5,178,792 | — | 27 Dec 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
1.4%
|
1,500,000
|
$4,260,000 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.3%
|
1,432,865
|
$4,069,337 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
1,330,384
|
$3,778,291 | — | 31 Mar 2024 | |
| Patrick D. Yeramian |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
239,375
mixed-class rows
|
$3,357,139 | — | 09 Jan 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,150,221
|
$3,266,628 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.97%
|
1,066,245
|
$3,028,492 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.95%
|
1,042,583
|
$2,960,935 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.94%
|
1,027,620
|
$2,918,441 | — | 31 Mar 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.92%
|
1,011,412
|
$2,872,410 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.92%
|
1,008,607
|
$2,864,444 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.89%
|
970,555
|
$2,757,000 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.86%
|
944,063
|
$2,681,139 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.84%
|
914,727
|
$2,597,825 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.73%
|
798,900
|
$2,268,876 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.69%
|
756,169
|
$2,147,520 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.64%
|
704,600
|
$2,001,000 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.48%
|
526,688
|
$1,495,794 | — | 31 Mar 2024 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.48%
|
524,627
|
$1,489,941 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.48%
|
523,772
|
$1,487,512 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.46%
|
500,000
|
$1,420,000 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.45%
|
498,000
|
$1,414,320 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.4%
|
435,903
|
$1,237,965 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.39%
|
425,567
|
$1,208,611 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.37%
|
409,759
|
$1,163,716 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.35%
|
378,798
|
$1,075,788 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.33%
|
361,870
|
$1,027,711 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.33%
|
361,722
|
$1,027,290 | — | 31 Mar 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.31%
|
341,517
|
$969,908 | — | 31 Mar 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.3%
|
331,451
|
$941,321 | — | 31 Mar 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.28%
|
306,729
|
$871,110 | — | 31 Mar 2024 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.27%
|
300,000
|
$852,000 | — | 31 Mar 2024 | |
| SHERBROOKE PARK ADVISERS LLC |
13F
|
Company |
0.27%
|
299,452
|
$850,444 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.25%
|
275,956
|
$783,715 | — | 31 Mar 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.24%
|
267,250
|
$758,990 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.23%
|
246,799
|
$700,909 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.02%
|
23,842
|
$671,747 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.2%
|
222,722
|
$632,530 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
210,573
|
$598,027 | — | 31 Mar 2024 |
Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) as of Q2 2024
As of 30 Jun 2024,
Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,632,024 shares.
The largest 10 holders included
VANGUARD GROUP INC, AQR CAPITAL MANAGEMENT LLC, BlackRock Inc., GOLDMAN SACHS GROUP INC, Almitas Capital LLC, Alyeska Investment Group, L.P., MILLENNIUM MANAGEMENT LLC, 683 Capital Management, LLC, Boxer Capital, LLC, and CITADEL ADVISORS LLC.
This page lists
115
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
138
Q2 2024 holders
115
Holder diff
-23
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.